AzTrials
AzTrials

Respiratory FailureNCT01900990

Noninvasive Positive Pressure Ventilation for Difficult Weaning in Tracheotomy Patients

A study testing Noninvasive ventilation weaning in people with Respiratory Failure, run by Chongqing Medical University at 2 sites in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators adopt Noninvasive Positive Pressure Ventilation for weaning in tracheotomy patients innovatively. The investigators randomly allocate the subjects into two groups. One group is weaned by traditional strategy. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Respiratory Failure
What is being tested?
Noninvasive ventilation weaning
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
2 sitesChina
Study dates
Jul 2009to Oct 2011
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • age ≥ 18 years
  • tracheotomy mechanical ventilation patients

Who cannot join

  • pregnancy
  • respiratory and hemodynamic instability
  • Recent oral,nasal,facial or cranial trauma or surgery
  • contra-indications for nasal or facial mask (facial skin lesions,...)
  • recent history of upper gastro-intestinal surgery
  • recent history of myocardial infarction
  • unconscious patients
  • non cooperative patient

Trial locations and contacts

2 sites in 1 country.

China2 sites
  • The First Affiliated Hospital ,Chongqing Medical Univercity

    Chongqing, Chongqing Municipality, 400016

  • The First Affiliated Hospital ,Chongqing Medical Univercity

    Chongqing, Chongqing Municipality, 40016

Other trials in China

About this study

Official title: A Randomized Controlled Trial of Noninvasive Positive Pressure Ventilation for Weaning From Mechanical Ventilation in Tracheotomy Patients

The investigators adopt Noninvasive Positive Pressure Ventilation for weaning in tracheotomy patients innovatively. The investigators randomly allocate the subjects into two groups. One group is weaned by traditional strategy. The other one is weaned by Noninvasive Positive Pressure Ventilation by plugging the tracheotomy tube and deflating the cuff.

Read the detailed description

The investigators adopt Noninvasive Positive Pressure Ventilation for weaning in tracheotomy patients innovatively .If patients'conditions met our defined criterions, the investigators randomly allocate two groups. One group adopts traditional weaning strategy, the other adopts Noninvasive Positive Pressure Ventilation. If patients' condition deteriorated in group two, the investigators turned them to invasive positive pressure ventilation, until patients adapted in a satisfactory condition, the investigators shift them into Noninvasive Positive Pressure Ventilation. The investigators will extubate the tracheotomy tube, if patients are received Noninvasive Positive Pressure Ventilation more than 24 to 48 hours. After extubation, the investigators try to wean Noninvasive Positive Pressure Ventilation. Successful wean is defined weaning mechanical ventilation more than 48 hours.

Being tested
Noninvasive ventilation weaning
Keywords
Noninvasive Positive Pressure Ventilation, Invasive Positive Pressure Ventilation, tracheotomy
Medical subject headings
Respiratory Insufficiency

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Noninvasive ventilation weaningDevice

    Also called capping tracheotomy tube

    We adopt Noninvasive Positive Pressure Ventilation in tracheotomy patients by capping the tracheotomy tube and deflating the cuff

Study groups in NCT01900990
Study groupRoleWhat they receive
Noninvasive ventilation weaningExperimentalPatients in this group were weaned by noninvasive ventilation
Receives: Device: Noninvasive ventilation weaning
Conventional weaningNo interventionPatients in this group were weaned by conventional stratiges.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Main end-point defined as total duration of mechanical ventilation

    The total duration of mechanical ventilation was measured from the patient admitted to hospital to discharge from it or death, an expected average of 2 months.

    Measured: from admission to hospital to discharge from it or death

Secondary outcomes (6)
  1. duration of invasive mechanical ventilation

    The duration of invasive mechanical ventilation was measured from the patient admitted to hospital to discharge from it or death, an expected average of 2 months.

    Measured: from admission to hospital to discharge from it or death

  2. duration of extubation tracheotomy tube

    The duration of extubation tracheotomy tube was measured from the patient admitted to hospital to discharge from it or death, an expected average of 2 months.

    Measured: from admission to hospital to discharge from it or death

  3. total duration of mechanical ventilation (invasive and non invasive)

    The total duration of mechanical ventilation (invasive and non invasive) was measured from the patient admitted to hospital to discharge from it or death, an expected average of 2 months.

    Measured: from admission to hospital to discharge from it or death

  4. successful weaning rate

    The sucessful weaning rate was measured from the patient admitted to hospital to discharge from it or death, an expected average of 2 months.

    Measured: from admission to hospital to discharge from it or death

  5. ICU length of stay

    The ICU lentgh of stay was measured from the patient admitted to hospital to discharge from it or death, an expected average of 2 months.

    Measured: from admission to hospital to discharge from it or death

  6. hospital length of stay

    The hospital lentgh of stay was measured from the patient admitted to hospital to discharge from it or death, an expected average of 2 months.

    Measured: from admission to hospital to discharge from it or death

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jul 2013 (estimated)
  2. Study startJul 2009
  3. Primary completionOct 2011
  4. Study completionOct 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
32 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01900990
Sponsor's protocol ID
CQYKDXFSDYYY
Status last verified
Jul 2013
First submitted
26 Jul 2010
Last updated
17 Jul 2013
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Noninvasive ventilation weaning in people with Respiratory Failure, run by Chongqing Medical University at 2 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Jul 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Main end-point defined as total duration of mechanical ventilation (time frame: from admission to hospital to discharge from it or death). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in